Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 62.88m | 0.98% |
| Gross profit | 31.95m | 2.08% |
| Net profit | 3.37m | 35.09% |
| EBITDA | 7.18m | 17.89% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €211.75m |
Number of shares | 17.01m |
52-week high/low | €13.95 - €12.10 |
Dividend yield | 4.21% |
Dividends TTM | €0.53 |
Beta | 0.50 |
P/E ratio | 16.42 |
PEG ratio | -1.72 |
P/B ratio | 1.54 |
P/S ratio | 0.84 |
Company profile
Prim, S.A., through its subsidiaries, designs, manufactures, and commercializes orthopedic products for physiotherapy, thalassotherapy, hydrotherapy, rehabilitation, spa, geriatrics, and support techniques in Spain and internationally. The company offers products for neuro-trauma, cardiovascular, neuromodulation, operating rooms, endo-surgery, plastic surgery, and ENT. It also engages in management of wellness projects, including hotels, resorts, and club sports. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.
| Name | PRIM |
| CEO | Fernando Oliveros Arreaga |
| Headquarters | Móstoles,
ma Spain |
| Website | |
| IPO | 01/04/2005 |
| Employees | 959 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Bme | PRM.MC |
Frankfurt | 5P1.F |
Düsseldorf | 5P1.DU |
Madrid | PRM.MC |
London | 0FP0.L |
München | 5P1.MU |